FluidAI Medical's Origin™ device receives FDA 510(k) clearance

FluidAI Medical, a Canadian medical technology company that develops artificial intelligence solutions integrating novel sensors, medical devices and software, received FDA 510(k) clearance for Origin™, a real-time monitoring device intended for use with patients recovering from surgery post-operatively.

Origin™ can either work as a standalone device and is planned to be integrated with FluidAI's Stream Care™ - an AI-assisted Surgical Expert Suite. The device has been designed to seamlessly connect to standard surgical drains and continuously provide care teams with real-time pH data visualization at the bedside.

FluidAI Medical is an OBIO® member, an alumnus of our BDSP™, CAAP®, EAHN™, H2BB™, HealthMINT™, Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence and WiHI programs, and presented at the OBIO® Investment Summit.